Mangoceuticals (MGRX) EBIT Margin (2023 - 2026)
Mangoceuticals (MGRX) posted EBIT Margin of 4606.75% for Q1 2026, down 1082.07% sequentially from 389.72% in Q4 2025, and down 42000.0% YoY from N/an in Q1 2025.
Mangoceuticals (MGRX) EBIT Margin (2023 - 2026) Analysis & Trends
Mangoceuticals has reported EBIT Margin for 4 years, with the latest figure at 4606.75% in Q1 2026.
- Quarterly EBIT Margin fell 42000.0% year-over-year to 4606.75% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3933.02% (down 194103.0% YoY) and the FY2025 annual result came in at 3954.28%, down 265986.0% from the prior year.
- EBIT Margin eased to 4606.75% in Q1 2026 per MGRX's latest filing, from 389.72% in the prior quarter.
- Over five years, EBIT Margin peaked at 389.72% in Q4 2025 and troughed at 8953.45% in Q3 2025.
- A 4-year average of 2505.12% and a median of 1594.02% in 2024 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2024 and 2025: EBIT Margin soared 143491 bps in 2024, then tumbled 763524 bps in 2025.
- Over 4 years, EBIT Margin stood at 1050.87% in 2023, then sank by 52 bps to 1594.02% in 2024, then jumped by 76 bps to 389.72% in 2025, then tumbled by 1082 bps to 4606.75% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 4606.75%, 389.72%, and 8953.45% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 30.93% |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 3.37% |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 29.03% |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -12.95% |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 19.00% |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | -11.11% |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 23.79% |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 21.48% |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | -27.93% |
| 10 | Mangoceuticals | 9.55 Mn | 9.30 Mn | 44,215.00 | -1,502.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,502.45% |
| Mar 31, 2026 | -4,606.75% |
| Dec 31, 2025 | -389.72% |
| Sep 30, 2025 | -8,953.45% |
| Jun 30, 2025 | -3,133.98% |
| Mar 31, 2025 | -4,186.75% |
| Dec 31, 2024 | -1,594.02% |
| Sep 30, 2024 | -1,318.21% |
| Jun 30, 2024 | -1,329.13% |
| Mar 31, 2024 | -1,105.87% |
| Dec 31, 2023 | -1,050.87% |
| Sep 30, 2023 | -733.99% |
| Jun 30, 2023 | -1,622.99% |
| Mar 31, 2023 | -2,540.78% |